Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
METTL3-IN-13
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | METTL3-IN-13 is a METTL3 inhibitor utilized in research on various cancers, including hypopharyngeal squamous cell carcinoma and non-small cell lung cancer. |
| In vitro | METTL3-IN-13 (Compound 142) (72 h) potently reduces the viability of Calu-6, A549, Fadu, HCT-116, MDA-MB-231, PANC-1, 5637, DU 145, and PC-3 cells, with IC50 values ≤ 200 nM. |
| In vivo | METTL3-IN-13 (Compound 142), administered intraperitoneally at a dose of 30 mg/kg daily for 20 days, effectively inhibits the growth of subcutaneous hypopharyngeal squamous cell carcinoma tumors and extends the survival of female NSG mice. Moreover, a 50-day regimen of METTL3-IN-13 at the same dose significantly prolongs the survival of female C.B-17 SCID mice in an orthotopic non-small cell lung adenocarcinoma model. |
| Molecular Weight | 462.59 |
| Formula | C25H34N8O |
| Cas No. | 3079150-70-9 |
| Smiles | C(C)(N1C=C(N=N1)C=2C=C(N(C)C)C=NC2)N3C(=O)C=C(C=C3)N4C[C@H](NCC5CC5)CCC4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.